Harel Insurance Investments & Financial Services’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-700
Closed -$455K 853
2021
Q1
$455K Buy
+700
New +$144K 0.01% 509
2020
Q4
Sell
-1,200
Closed -$177K 778
2020
Q3
$177K Buy
+1,200
New +$172K 0.01% 321

Other funds holding RGEN

Harel Insurance Investments & Financial Services's RGEN Position: Q2 2021 in Review

Harel Insurance Investments & Financial Services sold out of Repligen (RGEN) in Q2 2021, closing a stake of 700 shares — an estimated $455K sold.

Harel Insurance Investments & Financial Services first reported a position in RGEN in Q3 2020 and held it in 2 quarters. The position peaked at $455K in Q1 2021. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 700 Repligen shares in Q2 2021, an estimated $455K.
  • Harel Insurance Investments & Financial Services first reported a position in Repligen in Q3 2020 and held it in 2 quarters.
  • Harel Insurance Investments & Financial Services's Repligen position peaked at $455K in Q1 2021.
  • 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2021, filed 26 Jul 2021.